Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

Introduction: Identifying neoadjuvant chemotherapy (NAC) response in patients with muscle invasive bladder cancer (MIBC) has had limited success based on clinicopathological features and molecular subtyping. Identification of chemotherapy responsive cohorts would facilitate delivery to those most li...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Neal, Shih, Andrew J., Shah, Paras, Yaskiv, Oksana, Khalili, Houman, Liew, Anthony, Lee, Annette T., Zhu, Xin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629806/
https://www.ncbi.nlm.nih.gov/pubmed/36322407
http://dx.doi.org/10.18632/oncotarget.28302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629806/
https://www.ncbi.nlm.nih.gov/pubmed/36322407
http://dx.doi.org/10.18632/oncotarget.28302

Ejemplares similares